We are live on ! Find out more
MAM

Monaco Asset Management Portfolio holdings

AUM $1.26B
1-Year Est. Return 60.23%
This Fund
S&P 500
This Quarter Est. Return
+18.94%
1 Year Est. Return
+60.23%
3 Year Est. Return
+119.64%
5 Year Est. Return
10 Year Est. Return
AUM
$331M
AUM Growth
+$70.7M
Cap. Flow
+$23.7M
Cap. Flow %
7.14%
Top 10 Hldgs %
51.22%
Holding
94
New
25
Increased
23
Reduced
17
Closed
17

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$7.99M
2
AA icon
Alcoa
AA
+$4.57M
3
B
Barrick Mining
B
+$3.98M
4
GSK icon
GSK
GSK
+$3.1M
5
NOV icon
NOV
NOV
+$2.73M

Sector Composition

Rank Sector Weight
1 Miscellaneous 32.74%
2 Energy 20.1%
3 Healthcare 16.59%
4 Materials 12.08%
5 Technology 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMO icon
26
Bank of Montreal
BMO
$121B
$4.05M 1.22%
+44,700
New +$4.14M
ZYME icon
27
Zymeworks
ZYME
$1.97B
$3.93M 1.19%
+500,000
New +$3.51M
FET icon
28
Forum Energy Technologies
FET
$944M
$3.36M 1.01%
113,788
-45,847
-29% -$1.25M
PYPL icon
29
PayPal
PYPL
$45.3B
$3.32M 1%
46,669
+24,169
+107% +$1.93M
ORIC icon
30
Oric Pharmaceuticals
ORIC
$1.34B
$3.28M 0.99%
557,430
+216,248
+63% +$730K
FTCH
31
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$3.04M 0.92%
642,100
+412,100
+179% +$2.87M
ESPR
32
DELISTED
Esperion Therapeutics
ESPR
$2.93M 0.88%
470,100
+210,100
+81% +$1.5M
FXI icon
33
iShares China Large-Cap ETF
FXI
$4.08B
$2.83M 0.85%
+100,000
New +$2.59M
KOD icon
34
Kodiak Sciences
KOD
$2.06B
$2.82M 0.85%
393,366
+66,155
+20% +$475K
NOV icon
35
NOV
NOV
$7.32B
$2.72M 0.82%
130,000
-130,000
-50% -$2.73M
AU icon
36
AngloGold Ashanti
AU
$51.8B
$2.62M 0.79%
134,900
-75,100
-36% -$1.23M
FATE icon
37
Fate Therapeutics
FATE
$302M
$2.52M 0.76%
+250,000
New +$4.7M
MSOS icon
38
AdvisorShares Pure US Cannabis ETF
MSOS
$977M
$2.45M 0.74%
350,000
+240,000
+218% +$2.47M
META icon
39
CALL
Meta Platforms (Facebook)
META
$1.74T
$2.41M 0.73%
+20,000
New +$2.35M
HL icon
40
Hecla Mining
HL
$12.7B
$2.22M 0.67%
400,000
+200,000
+100% +$994K
TSP
41
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$1.91M 0.58%
+1,166,146
New +$4.15M
PSLV icon
42
Sprott Physical Silver Trust
PSLV
$13.4B
$1.9M 0.57%
230,000
OXY icon
43
PUT
Occidental Petroleum
OXY
$59.3B
$1.57M 0.48%
+25,000
New +$1.7M
NBIS
44
Nebius Group N.V.
NBIS
$59.3B
$1.56M 0.47%
105,000
MREO
45
Mereo BioPharma
MREO
$46.3M
$1.54M 0.46%
2,049,661
+1,863,005
+998% +$1.53M
CUE icon
46
Cue Biopharma
CUE
$275M
$1.42M 0.43%
16,573
+1,278
+8% +$117K
BIG
47
DELISTED
Big Lots, Inc.
BIG
$1.39M 0.42%
+94,711
New +$1.63M
BHC icon
48
Bausch Health
BHC
$2.11B
$1.37M 0.41%
+217,500
New +$1.52M
SBSW icon
49
Sibanye-Stillwater
SBSW
$8.53B
$1.33M 0.4%
124,358
NEOG icon
50
CALL
Neogen
NEOG
$2.8B
$1.08M 0.33%
+70,800
New +$1.01M

Similar funds

Monaco Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Monaco Asset Management held 94 positions worth $331M, up 27% from $261M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Monaco Asset Management deployed $23.7M of net new capital in Q4 2022, opening 25 new positions and adding to 23 existing holdings. Its largest new stake was Fate Therapeutics: 250,000 shares worth $2.52M.

By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, down from 33% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Viatris, an estimated $7.99M trimmed.

  • Monaco Asset Management's largest Q4 2022 buy was Fate Therapeutics: 250,000 shares worth $2.52M.
  • Monaco Asset Management added most to LendingTree in Q4 2022, an estimated $7.19M increase.
  • Monaco Asset Management's biggest Q4 2022 reduction was Viatris, cutting an estimated $7.99M.
  • Monaco Asset Management fully exited GSK in Q4 2022, selling an estimated $3.1M.
  • Monaco Asset Management's ten largest holdings make up 51% of its $331M portfolio in Q4 2022.
  • Monaco Asset Management opened 25 new positions and closed 17 in Q4 2022.
  • Monaco Asset Management's portfolio value rose 27% quarter-over-quarter to $331M.

Based on Monaco Asset Management's 13F filing for Q4 2022, filed 31 Jan 2023.